Biomodal releases genetics and epigenetics solution
Product delivers epigenetic information from a single low-input DNA library without medical treatment - News - PharmaTimes
Source: pharmatimes.com
Peter Fromen News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Peter Fromen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Peter Fromen Today - Breaking & Trending Today
BIOMODAL LAUNCHES SOLUTION TO SIMULTANEOUSLY SEQUENCE GENETICS AND EPIGENETICS IN ONE WORKFLOW
Biomodal (formerly known as Cambridge Epigenetix) commercially launches its new duet multiomics solution, revealing the combinatorial power of genetic and...
Source: prnewswire.com
Cambridge Epigenetix Names Peter Fromen as Chief Executive Officer
Genomics Veteran to Lead Company Which Has a Commercial-Ready Novel Technology Platform that Can Realize the Largely Untapped Contribution of Epigenetics to Human HealthCAMBRIDGE, United Kingdom, June
Source: finanznachrichten.de
Pacific Biosciences Partners with Japan's iLAC, RBI on Automated Sequencing Workflows
The automated workflows will use the Robotic Biology Institute's LabDroid to support whole-genome sequencing, targeted sequencing, and RNA isoform sequencing.
Source: genomeweb.com
Clearwater Capital Advisors LLC Has $213,000 Stock Holdings in Pacific Biosciences of California, Inc. (NASDAQ:PACB)
Clearwater Capital Advisors LLC boosted its holdings in shares of Pacific Biosciences of California, Inc. (NASDAQ:PACB – Get Rating) by 15.1% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 10,394 shares of the biotechnology company’s stock after buying an […]
Source: etfdailynews.com